Amedeo's Top 20

Amedeo Smart

Independent Medical Education


06 November 2023

Multidisciplinary Journal Club

  1. Parks AL, Stevens SM.
    In intermediate- or high-risk PE, catheter-directed thrombolysis is linked to reduced mortality vs. systemic thrombolysis or anticoagulation.
    Ann Intern Med 2023;176:JC118.

  1. Kuriyama K, Murakami K, Masuda T, Sugiura K, et al.
    Immunogenicity and safety of a single booster dose of NVX-CoV2373 (TAK-019) in healthy Japanese adults who had previously received a primary series of COVID-19 mRNA vaccine: Primary analysis report of a phase 3 open-label trial.
    Vaccine 2023.

  2. Hassel JC, Piperno-Neumann S, Rutkowski P, Baurain JF, et al.
    Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma.
    N Engl J Med 2023.

  3. Lee YJ, Hong SJ, Kang WC, Hong BK, et al.
    Rosuvastatin versus atorvastatin treatment in adults with coronary artery disease: secondary analysis of the randomised LODESTAR trial.
    BMJ 2023;383:e075837.

  4. Juanola A, Ma AT, de Wit K, Gananandan K, et al.
    Novel prognostic biomarkers in decompensated cirrhosis: a systematic review and meta-analysis.
    Gut 2023.

  1. Wattacheril JJ, Abdelmalek MF, Lim JK, Sanyal AJ, et al.
    AGA Clinical Practice Update on the Role of Noninvasive Biomarkers in the Evaluation and Management of Nonalcoholic Fatty Liver Disease: Expert Review.
    Gastroenterology 2023;165:1080-1088.

  2. Peel TN, Astbury S, Cheng AC, Paterson DL, et al.
    Trial of Vancomycin and Cefazolin as Surgical Prophylaxis in Arthroplasty.
    N Engl J Med 2023;389:1488-1498.

  3. Hasan T, Medcalf E, Nyang'wa BT, Egizi E, et al.
    The safety and tolerability of linezolid in novel short-course regimens containing bedaquiline, pretomanid and linezolid to treat rifampicin-resistant tuberculosis: an individual patient data meta-analysis.
    Clin Infect Dis 2023.

  4. Turner L, Charrouf R, Martinez-Vizcaino V, Hutchison A, et al.
    The effects of time-restricted eating vs habitual diet on inflammatory cytokines and adipokines in the general adult population: A systematic review with meta-analysis.
    Am J Clin Nutr 2023.

  5. Cheloor Kovilakam S, Gu M, Dunn WG, Marando L, et al.
    Prevalence and significance of DDX41 gene variants in the general population.
    Blood 2023;142:1185-1192.

  1. Soens MA, Sesso HD, Manson JE, Fields KG, et al.
    The effect of vitamin D and omega-3 fatty acid supplementation on pain prevalence and severity in older adults: a large-scale ancillary study of the VITamin D and OmegA-3 triaL (VITAL).
    Pain 2023.

  2. Everts-Graber J, Bonel H, Lehmann D, Gahl B, et al.
    Comparison of anti-fracture effectiveness of zoledronate, ibandronate and alendronate versus denosumab in a registry-based cohort study.
    Osteoporos Int 2023.

  3. Aleksovska K, Hershey AD, Deen M, Icco R, et al.
    Efficacy and safety of monoclonal antibodies targeting CGRP in migraine prevention. GRADE tables elaborated by the ad hoc working group of the International Headache Society.
    Cephalalgia 2023;43:333102423120616.

  4. Docherty AR, Mullins N, Ashley-Koch AE, Qin X, et al.
    GWAS Meta-Analysis of Suicide Attempt: Identification of 12 Genome-Wide Significant Loci and Implication of Genetic Risks for Specific Health Factors.
    Am J Psychiatry 2023;180:723-738.

  5. Wilson M, Harris M, Pereira M, Buckle J, et al.
    Predictors of hospitalisation and recovery following full antipsychotic discontinuation in first episode psychosis. A naturalistic retrospective cohort study.
    Schizophr Res 2023;261:269-274.

  1. Ontaneda D, Chitnis T, Rammohan K, Obeidat AZ, et al.
    Identification and management of subclinical disease activity in early multiple sclerosis: a review.
    J Neurol 2023.

  2. Belin AC, Barloese MC.
    The genetics and chronobiology of cluster headache.
    Cephalalgia 2023;43:333102423120812.

  3. Zloof Y, Tsur AM, Simchoni M, Derazne E, et al.
    Body mass index and migraine in adolescence: A nationwide study.
    Cephalalgia 2023;43:333102423120930.

  4. Zhang Y, Atkinson J, Burd CE, Graves J, et al.
    Biological aging in multiple sclerosis.
    Mult Scler 2023.

  5. Giantini-Larsen AM, Abou-Mrad Z, Yu KK, Reiner AS, et al.
    Treatment and outcomes of IDH1-mutant gliomas in elderly patients.
    J Neurosurg 2023.


more..


Privacy Policy